What is LOPJLB’s current signal on CBIO?

LOPJLB’s latest quantitative signal on Crescent Biopharma, Inc. (CBIO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CBIO in?

Crescent Biopharma, Inc. (CBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Crescent Biopharma, Inc. (CBIO) do?

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a …